11 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now.
10X Genomics Inc. (TXG)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 4,041,287 | $226,150,446 | +36% | 1.33% |
| 2. | Generation Investment Management David Blood And Al Gore | 1,531,392 | $85,696,697 | -1% | 0.38% |
| 3. | Alyeska Investment Group Anand Parekh | 708,849 | $39,667,190 | -2% | 0.26% |
| 4. | SRS Investment Management Karthik Sarma | 683,893 | $38,270,652 | -35% | 0.46% |
| 5. | Point72 Asset Management Steve Cohen | 497,282 | $27,827,901 | -64% | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $40.49 | 158 | Officer | 60,046 | 2022-05-13 | Filing | |
| $40.49 | 158 | Officer | 97,523 | 2022-05-13 | Filing | |
| $39.00 | 300,000 | Director | 300,000 | 2019-09-16 | Filing | |
| $39.00 | 300,000 | Director | 300,000 | 2019-09-16 | Filing | |
| $39.00 | 187,500 | Large Shareholder | 187,500 | 2019-09-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $44.00 | 4,660 | 842,900 | 2024-03-04 | Filing | ||
| $46.34 | 2,821 | 847,560 | 2024-02-22 | Filing | ||
| $46.34 | 2,613 | 283,059 | 2024-02-22 | Filing | ||
| $46.34 | 1,865 | 95,240 | 2024-02-22 | Filing | ||
| $49.43 | 1,700 | 850,381 | 2024-02-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,785,536 | $715,478,620 | 0.05% | |
| 2. | 9,011,332 | $504,274,139 | 0.01% | |
| 3. | 7,919,976 | $443,201,856 | 0.36% | |
| 4. | 5,705,392 | $319,273,759 | 0% | |
| 5. | 4,179,415 | $233,880,121 | 0.02% |
News See All
10x Genomics, Inc. (NASDAQ:TXG) Q4 2023 Earnings Call Transcript
10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.41 EPS, expectations were $-0.36. 10x Genomics, Inc.
12 Best Genomics Stocks To Buy Now
In this piece, we will take a look at the 12 best genomics stocks to buy now.
Harvard University Stocks List: Top 12 Picks
In this piece, we will take a look at Harvard University stocks list: top 12 picks.
Here’s Why You Should Invest in 10x Genomics (TXG)
Baron Funds, an investment management company, released its “Baron Discovery Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
10x Genomics, Inc. (NASDAQ:TXG) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. My name is Aaron, and I will be your conference operator for today.
Top 5 Genomics Companies in the World
10x Genomics, Inc. (NASDAQ:TXG) is a backend genomics company that provides products that help with gene mapping.
10x Genomics, Inc. (NASDAQ:TXG) Q1 2023 Earnings Call Transcript
Operator: Hello, everyone, and welcome to the 10x Genomics’ First Quarter 2023 Earnings Conference Call. My name is Bruno, and I will be the operator of today.
10x Genomics, Inc. (NASDAQ:TXG) Q4 2022 Earnings Call Transcript
Operator: Good afternoon. Thank you for attending today's 10x Genomics Fourth Quarter and Full Year 2022 Earnings Conference Call. My name is Bethany, and I will be the moderator for today's call.
4 Cheap Stocks to Buy According to Cathie Wood
ARK increased its holding in Twist Bioscience by 7% in the third quarter of this year, ending the period with 6.8 million shares of the company, worth $235.3 million.
Billionaire Hedge Funds
